Back |

MATTAWAN, MI October 23, 2009:

MPI Research, a preclinical Contract Research Organization (CRO), announced that it will be collaborating with Kineta, Inc, a Seattle-based privately held biotechnology company specializing in clinical advancement of drugs that modulate and enhance the human immune system. MPI Research will assist Kineta with advancing their promising autoimmune drug development program. This collaboration will enable phase one human trials to begin in 2010.

Dr. Tina Rogers, PhD, MBA, DABT, Director of Research and Executive Vice President at MPI Research, states, "We have a team of great scientists highly knowledgeable about autoimmune diseases and we are eager to collaborate with Kineta on their novel drug development program." Kineta President and CEO, Charles L. Magness, PhD concurs and says, "Partnering with a progressive company such as MPI Research allows Kineta to creatively advance our program, accelerating progress of our lead autoimmune drug into man. We look forward to a strong collaboration focused on shared goals. "

Kineta, Inc. was recently named one of the nation's top ten most promising biotechnology companies by the industry publication, Pharmaceutical Executive (August 2009). The article cited the company's experienced executive team, novel scientific programs, and investor-focused business model as factors driving the company's "ingenuity." Their strategic business model focuses a strong return for investors by developing life-changing classes of drugs that harness the power of the immune system to fight disease. Visit www.Kinetabio.com for more information on Kineta, Inc.

MPI Research, with global headquarters in Mattawan, Michigan, is one of the world's leading providers of comprehensive preclinical and early clinical research and development services. In addition to a wide array of drug safety evaluation services, MPI Research also has a Discovery Center that offers experimental therapeutics (in vivo, molecular and cell-based assays), experimental surgery, molecular imaging, drug metabolism, pharmacokinetics, and immunology. The company also offers medical device evaluation, bioanalytical and analytical testing, among other services. Learn more about the company's commitment to be the best at www.mpiresearch.com.

Home | News